-
Many second editions of lengthy publications are little more than minor rewrites and an updating of a smattering of facts here and there, but that hardly is the case with the American College of Occupational and Environmental Medicines second edition of Occupational Medicine Practice Guidelines a comprehensive guide that is the gold standard
in effective treatment of workplace injuries and diseases.
-
While disease management programs have steadily gained popularity in recent years, there is a relative lack of evidence that they improve quality and save money, according to a report from the Washington, DC-based Center for Studying Health System Change.
-
The latest technology in computerized sensory equipment may one day lead to smart buildings that can detect hazards and accidents, says a health informatics expert.
-
The following summary of selected abstracts from 3 meetings will be published in multiple parts. The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) met in Chicago September 14-17, 2003. The Infectious Disease Society of America (IDSA) met in San Diego October 9-12, 2003. The American Society of Tropical Medicine and Hygiene met in Philadelphia December 3-7, 2003.
-
Having automatic external defibrillators, or AEDs, installed in the workplace is of clear benefit, but there are a number of key strategies that should be followed to ensure program success, says Thomas W. Zoch, MD, FACP, FACEP, of Thedacare at Work in Appleton, WI.
-
The 50-year-old drug colistin was used successfully in 14 of 23 cases of serious infections caused by multiply resistant Pseudomonas aeruginosa .
-
ACOEM supports immigration reform; OSHA delays enforcement of TB standard to July; Survey finds vacancies, turnover; AHIMA releases EHR standards
-
Antibiotic administration for only 8 days to patients with ventilator-associated pneumonia was not inferior to 15 days of therapy.
-
A randomized, double-blind, placebo-controlled trial of short-course dexamethasone therapy as an adjunct to antimicrobial therapy was conducted among children 3 months to 11 years of age with hematogenous suppurative arthritis in Costa Rica from 1998 to 2000.
-
